Skip to main content

Table 1 Characteristics of participants (N = 100)

From: Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma

Feature

No of cases (%)

 

Total

Patients

Control

Overall

50

50

100

Gender

 Female

23 (46.0)

24 (48.0)

47 (47.0)

 Male

27 (54.0)

26 (52.0)

53 (53.0)

Age (years)

  ≤ 60

31 (62.0)

27 (54.0)

58 (58.0)

  > 60

19 (38.0)

23 (46.0)

42 (42.0)

Tobacco smoking

 Ever

17 (34.0)

19 (38.0)

36 (36.0)

 Never

33 (66.0)

31 (62.0)

64 (64.0)

Alcohol drinking

 Ever

15 (30.0)

18 (36.0)

33 (33.0)

 Never

35 (70.0)

32 (64.0)

67 (67.0)

Grade

 Low-grade glioma

24 (48.0)

 High-grade glioma

26 (52.0)

Tumor site

 Frontal lobe

15 (30.0)

 Temporal lobe

11 (22.0)

 Parietal lobe

6 (12.0)

 Occipital lobe

7 (14.0)

 Other

11 (22.0)

Ki-67 labeling index

 Negative (−)

10 (20.0)

 Weakly positive (+)

16 (32.0)

 Moderately positive (++)

14 (28.0)

 Strongly positive (+++)

10 (20.0)